Bentham Science Publishers, Mini-Reviews in Medicinal Chemistry, 7(9), p. 769-781
DOI: 10.2174/138955709788452621
Full text: Download
Neurodegenerative diseases associated with dementia are characterized by cognitive deficits and memory impairment, thus stimulating research for memory enhancing drugs. We survey here the state of the art of research and clinical trials on these drugs from cholinesterase inhibitors and drugs acting on neurotransmitter receptors to drugs acting on gene expression.